Stay updated on Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial

Sign up to get notified when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added two key research citations (with complete details) and removed/adjusted erratum notes for those citations; this improves bibliographic accuracy and credibility without changing core content or user-facing information.
    Difference
    0.4%
    Check dated 2025-10-13T07:33:51.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Major update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.
    Difference
    1%
    Check dated 2025-10-06T05:10:23.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Update: replaced 'Plasma cell myeloma' with 'Multiple myeloma' and added MedlinePlus Genetics topic with revision to v3.1.0. Deletion removes the older term and v3.0.2.
    Difference
    0.2%
    Check dated 2025-09-29T02:57:42.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Removed a MedlinePlus Genetics topic: Multiple myeloma, reducing the page’s coverage of that genetic topic. No new topics were added.
    Difference
    0.1%
    Check dated 2025-09-21T22:29:47.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Added a MedlinePlus Genetics topic for multiple myeloma and refreshed two major myeloma citations with newer revisions and corrections; one entry includes an Erratum, while the other shows the older revision.
    Difference
    0.5%
    Check dated 2025-09-14T18:52:39.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The page has been updated to version 3.0.1, and the previous version 3.0.0 has been removed. Additionally, the topic of multiple myeloma related to MedlinePlus Genetics has been deleted.
    Difference
    0.2%
    Check dated 2025-09-07T13:35:06.000Z thumbnail image

Stay in the know with updates to Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.